Aspen Pharmacare Holdings Ltd (APNJ.J)
22,405.00ZAc
2 Jul 2013
55.00c (+0.24%)
22,450.00c
22,500.00c
22,649.00c
22,101.00c
1,093,494
1,108,273
22,943.00c
12,245.00c
APNJ.J
About
Overall
| Beta: | 0.61 |
| Market Cap (Mil.): | R102,313.40 |
| Shares Outstanding (Mil.): | 455.74 |
| Dividend: | 157.00 |
| Yield (%): | 0.69 |
Financials
| APNJ.J | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 33.48 | 32.01 | 32.18 |
| EPS (TTM): | 6.71 | -- | -- |
| ROI: | 12.23 | 19.61 | 18.91 |
| ROE: | 17.41 | 20.45 | 19.87 |
UPDATE 1-Aspen adds $1 bln deal with Merck to drug acquisition drive
JOHANNESBURG, June 27 - South Africa's Aspen Pharmacare said on Thursday it would acquire drugs and a manufacturing business from U.S. drugmaker Merck in a $1 billion deal to bolster its presence in Europe, Latin America and Asia.
BRIEF-South Africa's Aspen in $1 bln deal with Merck
JOHANNESBURG, June 27 - Aspen Pharmacare Holdings Ltd : * Signing of an agreement to acquire api manufacturing facilities * Agreement on an option to acquire a portfolio of products from msd * Agreement with Merck for the acquisition of an active pharmaceutical
UPDATE 1-GSK negotiating $1 bln sale of thrombosis drugs to Aspen
* Aspen offers to buy Arixtra and Fraxiparine, plus factory
BRIEF-Aspen Pharmacare says H1 headline earnings rise
JOHANNESBURG, March 7 - Aspen Pharmacare Holdings Ltd : * Says revenue from continuing operations increased 20% to R9,0 billion * Says operating profit from continuing operations increased 24% to R2,5
BRIEF-Aspen Pharmacare says expects higher H1 earnings
JOHANNESBURG, Feb 21 - Aspen Pharmacare Holdings Ltd : * Says H1 headline earnings per share are expected to exceed those reported in
BRIEF-Aspen says in talks to buy pharmaceutical ingredient facility in Netherlands
JOHANNESBURG, Feb 4 - Aspen Pharmacare Holdings Ltd : * Says Aspen is currently engaged in discussions with msd * Says talks in respect of possible acquisition of an active pharmaceutical
Earnings vs. 
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: GlobalData
|
$250.00
|
|
Provider: GlobalData
|
$125.00
|
|
Provider: GlobalData
|
$125.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
